In Your Area
American Liver Foundation
127 Washington Avenue
North Haven, CT 06473
American Liver Foundation
39 Broadway, Suite 2700
New York, New York 10006
127 Washington Ave, North Haven, CT 06473
National Helpline: 1-800-GO-LIVER
My name is Dr. Robert Leventhal and I am the new Chairman of the Connecticut Division of the American Liver Foundation. Alhtough board members and division heads within our organization change, the one constant that remains is our mission to educate people about liver and liver diseases, many of which may still be poorly understood by both lay public and medical professionals.
If you are visiting our website, then you have an interest in liver disease. Perhaps you have liver disease of know someone with liver disease and want to learn more about the condition and its treatment. We want you to get the most helpful and update information available from our site. Our division is committed to working with you to support your needs and help to answer any questions regarding liver disease that you may have.
My primary goal over the next two years as Chairman is to extend our mission and help to expand the public's understanding of all liver diseases far beyond the more common disorders such as alcoholic liver disease and viral hepatitis.
Unfortunately, there are thousands of people who are unaware that they may be at risk or have liver disease already. We are trying to connect with these patients. Our Connecticut Division currently has the most active division nationally- reaching 25,000 children and young adults with the Love Your Liver initiative. We have a Treatment Choices Initiative Program (TCI) educationg people who have or are at risk for Hepatitis C, the most common cause of liver disease that can lead to liver transplantation. Hepatitis B is still a major problem worldwide, and it is 100% preventable with vaccination. By increasing awareness, we can have an enormous impact on preventing liver disease and its comlications. With better understanding, we can also help to identify those patients at risk and direct them to the appropriate places where treatment is available.
Another major project for this year includes the development of a program about how obesity affects the liver (Fatty Liver disease). 300,000 people die every year in the US from the deleterious effects of morbid obesity. Fatty Liver disease is just another damaging consequence of the obesity epidemic, in addition to diabetes and heart disease. It is now well known that some cases of Fatty Liver can progress to cirrhosis and all of its attendant complications.
Our Board and various Committees are actively working towards measurable goals to increase awareness about the diagnosis, management, and prevention of liver diseases including better understanding of complex issues such as liver transplantation and organ donation as well. This is just one of the many functions our division.
Please visit our site often and feel free to contact us with your questions and suggestions.
Robert Leventhal, MD